TrialJAMA network open2026

Streamlining Inherited Cancer Identification via an EMR-Integrated Risk Assessment Platform: A Nonrandomized Clinical Trial.

Lori A Orlando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.